ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Mechanism for immune-mediated drug-induced thrombotic microangiopathy (DITMA) and other systemic reactions caused by quinine

Mechanism for immune-mediated drug-induced thrombotic microangiopathy (DITMA) and other systemic reactions caused by quinine
(A) Naturally occurring antibodies that react very weakly with antigens on autologous cells* may be present in certain individuals.
(B) Drugs can bind to the complementarity-determining regions (CDR) of the naturally occurring antibodies, remodeling their structure and increasing their binding affinity to the antigenic epitopes by >10,000-fold. The physiologic response to antigen-antibody binding provokes cell injury and TMA. These antibodies persist for years; subsequent drug exposure can cause an immediate reaction.
CDR: complementarity-determining region; GP IIb/IIIa: platelet glycoprotein IIb/IIIa; TMA: thrombotic microangiopathy.
* Quinine-dependent antibodies have been demonstrated to bind platelet glycoprotein alphaIIb-beta3 (GP IIb/IIIa), and it is assumed that this mechanism also occurs on vascular endothelial cells and other tissues. Refer to the source document and UpToDate for additional citations.
George JN, Morton JM, Liles NW, Nester CM. After the party's over. N Engl J Med 2017; 376:74. Copyright © 2017 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
Graphic 130247 Version 3.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟